• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • JobWatch
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » New U.K. health campaign urges people with diabetes to 'TALK Hypos'

New U.K. health campaign urges people with diabetes to 'TALK Hypos'

October 16, 2014
CenterWatch Staff

The TALK Hypos awareness campaign has launched in the U.K., supported by Novo Nordisk and Diabetes U.K., encouraging people with diabetes to report hypoglycemia (hypos) to their doctor or nurse.

There are about 3.2 million people diagnosed with diabetes in the U.K., and hypos are one of the most common diabetes complications. Hypos are when glucose in the blood falls to a low level, and symptoms can include a pounding heart, trembling, hunger, difficulty concentrating and blurred vision. Left untreated, hypos can become serious and cause unconsciousness. Despite this, hypos remain under-recognized and under-reported by patients.

Simon O'Neill, director of health intelligence for Diabetes U.K., said, "People with diabetes can fail to report hypos to clinicians for a range of reasons, including lack of awareness, a fear of losing their driving license and a belief that their healthcare professional is unable to make a difference. To make matters worse, we know that people with diabetes and their families are often fearful of hypos and feel powerless to do anything.”

"The first step is to help people with diabetes recognize the symptoms of hypos and better manage their condition by encouraging a regular discussion about them during consultations,” said O’Neill.

TALK Hypos provides an acronym to encourage people with diabetes to discuss hypoglycemia with their doctor or nurse:

  • THINK: Do you know what a hypo is? Do you suffer from hypos?
  • ASK your doctor or nurse about hypos and discuss them as part of your consultation
  • LEARN what can be done to better manage your hypos, including lifestyle and treatment options
  • KEEP track of your hypos for discussion with your healthcare professional.

As well as the more immediate symptoms, a few people may experience severe hypos, which can require emergency assistance. Regularly occurring, severe hypos have been linked to longer-term health complications including, in some instances, heart disease. Having repeated hypos can, over time, lead to “hypo unawareness,” when the warning symptoms of a hypo are no longer felt, making hypos harder to identify and more difficult to manage.

O'Neill said, "We would encourage all people with diabetes to remember the simple TALK Hypos message and remember that steps can be taken to better manage hypos, including simple changes to lifestyle, diet and treatment. It is very important to discuss hypos as part of the regular consultation with your doctor or nurse."

Klaus Henning Jensen, director of clinical, medical and regulatory, Novo Nordisk, said, "Novo Nordisk is proud to support the TALK Hypos campaign, which aims to improve awareness of hypos as part of ‘Changing Diabetes: a global commitment to improving conditions for the millions of people who live with diabetes around the world today, and those who are at risk of developing diabetes tomorrow.’ "

The TALK Hypos campaign comprises patient education materials and an education video hosted on the Diabetes U.K. and Novo Nordisk web sites.

Upcoming Events

  • 25May

    2022 WCG Avoca Quality & Innovation Summit: Own the Future

  • 28Jun

    Effective Root Cause Analysis and CAPA Investigations for the Life Sciences

  • 16Oct

    WCG MAGI's Clinical Research Hybrid Conference - 2022 West

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • Protocol-360x240.png

    Avoid Deviations by Making Protocol Review a Team Effort

  • SelectionProcess-360x240.png

    Give Us a Voice: Sites Clamor for a Say on Vendor Selection

  • Convince-360x240.png

    Use Data and Details to Convince Site Leadership to Add Staff

  • AsktheExpertsBadge-360x240.png

    Ask the Experts: Listing Trial Staff and Others on the Statement of Investigator

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell My Personal Information

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2022. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing